Correlation Between ABVC Biopharma and Mineralys Therapeutics,
Can any of the company-specific risk be diversified away by investing in both ABVC Biopharma and Mineralys Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ABVC Biopharma and Mineralys Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ABVC Biopharma and Mineralys Therapeutics, Common, you can compare the effects of market volatilities on ABVC Biopharma and Mineralys Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ABVC Biopharma with a short position of Mineralys Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of ABVC Biopharma and Mineralys Therapeutics,.
Diversification Opportunities for ABVC Biopharma and Mineralys Therapeutics,
-0.32 | Correlation Coefficient |
Very good diversification
The 3 months correlation between ABVC and Mineralys is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding ABVC Biopharma and Mineralys Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mineralys Therapeutics, and ABVC Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ABVC Biopharma are associated (or correlated) with Mineralys Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mineralys Therapeutics, has no effect on the direction of ABVC Biopharma i.e., ABVC Biopharma and Mineralys Therapeutics, go up and down completely randomly.
Pair Corralation between ABVC Biopharma and Mineralys Therapeutics,
Given the investment horizon of 90 days ABVC Biopharma is expected to under-perform the Mineralys Therapeutics,. In addition to that, ABVC Biopharma is 1.27 times more volatile than Mineralys Therapeutics, Common. It trades about -0.06 of its total potential returns per unit of risk. Mineralys Therapeutics, Common is currently generating about 0.03 per unit of volatility. If you would invest 1,258 in Mineralys Therapeutics, Common on September 12, 2024 and sell it today you would earn a total of 56.00 from holding Mineralys Therapeutics, Common or generate 4.45% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
ABVC Biopharma vs. Mineralys Therapeutics, Common
Performance |
| Timeline |
| ABVC Biopharma |
| Mineralys Therapeutics, |
ABVC Biopharma and Mineralys Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ABVC Biopharma and Mineralys Therapeutics,
The main advantage of trading using opposite ABVC Biopharma and Mineralys Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ABVC Biopharma position performs unexpectedly, Mineralys Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mineralys Therapeutics, will offset losses from the drop in Mineralys Therapeutics,'s long position.| ABVC Biopharma vs. Equillium | ABVC Biopharma vs. DiaMedica Therapeutics | ABVC Biopharma vs. Valneva SE ADR | ABVC Biopharma vs. Vivani Medical |
| Mineralys Therapeutics, vs. Equillium | Mineralys Therapeutics, vs. DiaMedica Therapeutics | Mineralys Therapeutics, vs. Valneva SE ADR | Mineralys Therapeutics, vs. Vivani Medical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |